Skip to main content
MEDP
NASDAQ Industrial Applications And Services

Medpace President Sells $14.4M in Shares Following Option Exercise

Analysis by Wiseek.ai
Sentiment info
Negative
Importance info
7
Price
$460.92
Mkt Cap
$13.082B
52W Low
$250.05
52W High
$628.916
Market data snapshot near publication time

summarizeSummary

Medpace President Jesse J. Geiger exercised options and sold 31,707 shares for $14.4 million, reducing his direct holdings.


check_boxKey Events

  • President Sells Shares

    Jesse J. Geiger, President of Medpace Holdings, sold 31,707 shares of common stock in an open market transaction on March 17, 2026, for a total value of $14,436,197.10 at a weighted average price of $455.30 per share.

  • Option Exercise Preceded Sale

    The sale was preceded by the exercise of employee stock options for 31,707 shares at an exercise price of $138.87 per share, totaling $4,403,151.09.

  • Follows Prior Intent to Sell

    This transaction directly executes the intent to sell 31,707 shares, as previously disclosed in a Form 144 filing on March 17, 2026.

  • Reduction in Direct Holdings

    Following these transactions, Mr. Geiger's direct holdings in Medpace Holdings, Inc. common stock are 15,000 shares.


auto_awesomeAnalysis

Medpace President Jesse J. Geiger executed a significant cash-out event, exercising options for 31,707 shares and immediately selling them for over $14.4 million. This transaction directly follows a Form 144 filing on March 17, 2026, which indicated an intent to sell the same number of shares. While the option exercise itself is a routine compensation event, the subsequent open market sale by a key executive is a notable negative signal, as it represents a substantial liquidation of holdings. Post-transaction, Mr. Geiger's direct holdings are reduced to 15,000 shares.

At the time of this filing, MEDP was trading at $460.92 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $13.1B. The 52-week trading range was $250.05 to $628.92. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed MEDP - Latest Insights

MEDP
Apr 22, 2026, 4:26 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
MEDP
Apr 22, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
7
MEDP
Apr 22, 2026, 4:15 PM EDT
Source: Reuters
Importance Score:
7
MEDP
Apr 01, 2026, 4:42 PM EDT
Filing Type: DEFA14A
Importance Score:
7
MEDP
Mar 19, 2026, 4:45 PM EDT
Filing Type: 4
Importance Score:
7
MEDP
Mar 17, 2026, 12:37 PM EDT
Filing Type: 144
Importance Score:
7
MEDP
Mar 16, 2026, 5:23 PM EDT
Filing Type: PRE 14A
Importance Score:
8
MEDP
Feb 10, 2026, 4:03 PM EST
Filing Type: 10-K
Importance Score:
7
MEDP
Feb 09, 2026, 4:15 PM EST
Filing Type: 8-K
Importance Score:
7